Tandem Diabetes Care (TNDM) Convertible Debt (2020 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Convertible Debt came in at $601.8 million in Q1 2026, up 94.93% YoY from $308.7 million in Q1 2025, and up 94.1% on a QoQ basis from $310.0 million in Q4 2025.
Tandem Diabetes Care (TNDM) Convertible Debt (2020 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 7 years of Convertible Debt data on file, last reported at $601.8 million in Q1 2026.
- Quarterly Convertible Debt rose 94.93% year-over-year to $601.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $601.8 million (up 94.93% YoY) and the FY2025 annual result came in at $310.0 million, up 0.57% from the prior year.
- Convertible Debt rose to $601.8 million in Q1 2026, from $310.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $601.8 million in Q1 2026 to a low of $281.9 million in Q1 2022.
- A 5-year average of $316.3 million and a median of $307.4 million in 2024 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2025 — Convertible Debt retreated 11.16% — and 2026, when it surged 94.93%.
- Tracing TNDM's Convertible Debt over 5 years: stood at $283.2 million in 2022, then increased by 0.64% to $285.0 million in 2023, then rose by 8.15% to $308.3 million in 2024, then climbed by 0.57% to $310.0 million in 2025, then soared by 94.1% to $601.8 million in 2026.
- The last three Convertible Debt figures came in at $601.8 million (Q1 2026), $310.0 million (Q4 2025), and $309.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 602.58 Mn |
| Mar 31, 2026 | 601.77 Mn |
| Dec 31, 2025 | 310.04 Mn |
| Sep 30, 2025 | 309.59 Mn |
| Jun 30, 2025 | 309.15 Mn |
| Mar 31, 2025 | 308.71 Mn |
| Dec 31, 2024 | 308.27 Mn |
| Sep 30, 2024 | 307.83 Mn |
| Jun 30, 2024 | 307.39 Mn |
| Mar 31, 2024 | 347.50 Mn |
| Dec 31, 2023 | 285.04 Mn |
| Sep 30, 2023 | 284.58 Mn |
| Jun 30, 2023 | 284.13 Mn |
| Mar 31, 2023 | 283.68 Mn |
| Dec 31, 2022 | 283.23 Mn |
| Sep 30, 2022 | 282.79 Mn |
| Jun 30, 2022 | 282.35 Mn |
| Mar 31, 2022 | 281.91 Mn |
| Dec 31, 2021 | 281.47 Mn |
| Sep 30, 2021 | 281.03 Mn |